Literature DB >> 11355255

Early and late outcomes after reoperation for prosthetic valve endocarditis.

Y Sasaki1, F Isobe, S Kinugasa, K Iwata, K Nagamachi, Y Kato, H Arimoto, H Hata.   

Abstract

OBJECTIVE: Prosthetic valve endocarditis remains a challenging complication after heart valve replacement. To identify predictive risk factors, we have reviewed 30 patients who underwent surgery for prosthetic valve endocarditis between March 1986 and May 1999.
METHODS: There were 15 men and 15 women (mean age 51 years). Prosthetic valve endocarditis was classified as early (< or = 1 year after operation) in 10 cases, and as late in the other 20 cases. The most common indication for surgery was moderate to severe congestive heart failure due to prosthetic valve dysfunction in 21 (70%) patients. The average follow-up period was 6.5 years, with a range of 0.3 to 14.1 years.
RESULTS: The most common microorganism was Staphylococcus epidermidis in both patients with early (50%) and late prosthetic valve endocarditis (25%). The in-hospital mortality was 13.3% (4/30). There were six late deaths. The actuarial survival at 5 years was 78% and 66% at 10 years. An early onset of prosthetic valve endocarditis was the only significant determinant of both in-hospital mortality (p = 0.005) and overall mortality (p = 0.021). Emergency surgery had a statistically significant relationship with in-hospital mortality (p = 0.045). No significant influence on mortality after reoperation for prosthetic valve endocarditis was found in age, sex, valve position, antecedent native valve endocarditis, or in the type of pathological findings (ring abscess, valve dehiscence, and vegetation).
CONCLUSION: Early onset of prosthetic valve endocarditis and emergency surgery were important risk factors for mortality due to prosthetic valve endocarditis.

Entities:  

Mesh:

Year:  2001        PMID: 11355255     DOI: 10.1007/bf02913520

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  14 in total

1.  [Clinical evaluation of treatment for prosthetic valve endocarditis and analysis of factors affecting outcome of surgical therapy].

Authors:  T Shimono; K Hatanaka; C Kondoh; T Mizumoto; T Sato; Y Katayama; M Okabe; I Yada; H Yuasa; M Kusagawa
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1992-02

Review 2.  The surgical treatment of patients with prosthetic valve endocarditis.

Authors:  T E David
Journal:  Semin Thorac Cardiovasc Surg       Date:  1995-01

Review 3.  Risk, diagnosis and management of prosthetic valve endocarditis: a review.

Authors:  A A Vlessis; A Khaki; G L Grunkemeier; H H Li; A Starr
Journal:  J Heart Valve Dis       Date:  1997-09

Review 4.  A practical approach to prosthetic valve endocarditis.

Authors:  L D Cowgill; V P Addonizio; A R Hopeman; A H Harken
Journal:  Ann Thorac Surg       Date:  1987-04       Impact factor: 4.330

5.  Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study.

Authors:  G Fang; T F Keys; L O Gentry; A A Harris; N Rivera; K Getz; P C Fuchs; M Gustafson; E S Wong; A Goetz; M M Wagener; V L Yu
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

6.  Incidence and risk factors of prosthetic valve endocarditis.

Authors:  A Arvay; M Lengyel
Journal:  Eur J Cardiothorac Surg       Date:  1988       Impact factor: 4.191

7.  Surgical treatment of prosthetic valve endocarditis.

Authors:  B W Lytle; B P Priest; P C Taylor; F D Loop; S K Sapp; R W Stewart; P M McCarthy; D Muehrcke; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  1996-01       Impact factor: 5.209

8.  Reoperation on prosthetic heart values. Patient-specific estimates of in-hospital events.

Authors:  J M Piehler; E H Blackstone; K R Bailey; M E Sullivan; J R Pluth; N S Weiss; R S Brookmeyer; J G Chandler
Journal:  J Thorac Cardiovasc Surg       Date:  1995-01       Impact factor: 5.209

9.  Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry.

Authors:  M B Edwards; C P Ratnatunga; C J Dore; K M Taylor
Journal:  Eur J Cardiothorac Surg       Date:  1998-08       Impact factor: 4.191

10.  Prosthetic valve endocarditis. An analysis of the outcome in 32 cases.

Authors:  M Otaki
Journal:  ASAIO J       Date:  1994 Apr-Jun       Impact factor: 2.872

View more
  1 in total

1.  Triple-valve treatment for prosthetic valve endocarditis occurring 20 years after implantation of a Carpentier-Edwards pericardial bioprosthesis in the aortic valve.

Authors:  Yoichi Hisata; Shiro Hazama; Kenta Izumi; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.